Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115865) titled 'Application of 68Ga-NOTA-BCMA Nanobody PET/CT Imaging in Non-Myeloma Hematologic Malignancies' on Dec. 31, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Condition:
Marginal zone lymphoma, Waldenstrom macroglobulinemia/Lymphoplasmacytic lymphoma, multicentric Castleman disease
Intervention:
Gold Standard:Histopathological evaluation
Recruitment Status: Not Recruiting
Phase: Diagnostic New Technique Clincal Study
Date of First Enrollment: 2026-01-01 ...